Your browser doesn't support javascript.
loading
Short-term and Long-term Outcomes of a Disruption and Disconnection of the Pancreatic Duct in Necrotizing Pancreatitis: A Multicenter Cohort Study in 896 Patients.
Timmerhuis, Hester C; van Dijk, Sven M; Hollemans, Robbert A; Sperna Weiland, Christina J; Umans, Devica S; Boxhoorn, Lotte; Hallensleben, Nora H; van der Sluijs, Rogier; Brouwer, Lieke; van Duijvendijk, Peter; Kager, Liesbeth; Kuiken, Sjoerd; Poley, Jan-Werner; de Ridder, Rogier; Römkens, Tessa E H; Quispel, Rutger; Schwartz, Matthijs P; Tan, Adriaan C I T L; Venneman, Niels G; Vleggaar, Frank P; van Wanrooij, Roy L J; Witteman, Ben J; van Geenen, Erwin J; Molenaar, I Quintus; Bruno, Marco J; van Hooft, Jeanin E; Besselink, Marc G; Voermans, Rogier P; Bollen, Thomas L; Verdonk, Robert C; van Santvoort, Hjalmar C.
Afiliação
  • Timmerhuis HC; Department of Research & Development, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • van Dijk SM; Department of Surgery, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • Hollemans RA; Amsterdam UMC, University of Amsterdam, Department of Surgery, Amsterdam, the Netherlands.
  • Sperna Weiland CJ; Amsterdam Gastroenterology Endocrinology Metabolism, the Netherlands.
  • Umans DS; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Boxhoorn L; Department of Gastroenterology and Hepatology, Radboud UMC, Nijmegen, the Netherlands.
  • Hallensleben NH; Amsterdam Gastroenterology Endocrinology Metabolism, the Netherlands.
  • van der Sluijs R; Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Brouwer L; Amsterdam Gastroenterology Endocrinology Metabolism, the Netherlands.
  • van Duijvendijk P; Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Kager L; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Kuiken S; Department of Radiology, Center for Artificial Intelligence in Medicine and Imaging Stanford University, Stanford, California, USA.
  • Poley JW; Department of Gastroenterology and Hepatology, Maasstad Hospital, Rotterdam, the Netherlands.
  • de Ridder R; Department of Surgery, Gelre Hospital, Apeldoorn, the Netherlands.
  • Römkens TEH; Department of Gastroenterology and Hepatology, Noordwest Hospitalgroup, Alkmaar, the Netherlands.
  • Quispel R; Department of Gastroenterology and Hepatology, OLVG, Amsterdam, the Netherlands.
  • Schwartz MP; Department of Gastroenterology and Hepatology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Tan ACITL; Department of Gastroenterology and Hepatology, Maastricht University Medical Center+, Maastricht, the Netherlands.
  • Venneman NG; Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
  • Vleggaar FP; Department of Gastroenterology and Hepatology, Reinier de Graaf Gasthuis, Delft, the Netherlands.
  • van Wanrooij RLJ; Department of Gastroenterology and Hepatology, Meander Medical Center, Amersfoort, the Netherlands.
  • Witteman BJ; Department of Gastroenterology and Hepatology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
  • van Geenen EJ; Department of Gastroenterology and Hepatology, Medical Spectrum Twente, Enschede, the Netherlands.
  • Molenaar IQ; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Bruno MJ; Amsterdam Gastroenterology Endocrinology Metabolism, the Netherlands.
  • van Hooft JE; Department of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit, Amsterdam Gastroenterology Endocrinology Metabolism, the Netherlands.
  • Besselink MG; Department of Gastroenterology and Hepatology, Hospital Gelderse Vallei, Ede, the Netherlands.
  • Voermans RP; Department of Gastroenterology and Hepatology, Radboud UMC, Nijmegen, the Netherlands.
  • Bollen TL; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Verdonk RC; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van Santvoort HC; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
Am J Gastroenterol ; 118(5): 880-891, 2023 05 01.
Article em En | MEDLINE | ID: mdl-36707931
ABSTRACT

INTRODUCTION:

Necrotizing pancreatitis may result in a disrupted or disconnected pancreatic duct (DPD) with the potential for long-lasting negative impact on a patient's clinical outcome. There is a lack of detailed data on the full clinical spectrum of DPD, which is critical for the development of better diagnostic and treatment strategies.

METHODS:

We performed a long-term post hoc analysis of a prospectively collected nationwide cohort of 896 patients with necrotizing pancreatitis (2005-2015). The median follow-up after hospital admission was 75 months (P25-P75 41-151). Clinical outcomes of patients with and without DPD were compared using regression analyses, adjusted for potential confounders. Predictive features for DPD were explored.

RESULTS:

DPD was confirmed in 243 (27%) of the 896 patients and resulted in worse clinical outcomes during both the patient's initial admission and follow-up. During hospital admission, DPD was associated with an increased rate of new-onset intensive care unit admission (adjusted odds ratio [aOR] 2.52; 95% confidence interval [CI] 1.62-3.93), new-onset organ failure (aOR 2.26; 95% CI 1.45-3.55), infected necrosis (aOR 4.63; 95% CI 2.87-7.64), and pancreatic interventions (aOR 7.55; 95% CI 4.23-13.96). During long-term follow-up, DPD increased the risk of pancreatic intervention (aOR 9.71; 95% CI 5.37-18.30), recurrent pancreatitis (aOR 2.08; 95% CI 1.32-3.29), chronic pancreatitis (aOR 2.73; 95% CI 1.47-5.15), and endocrine pancreatic insufficiency (aOR 1.63; 95% CI 1.05-2.53). Central or subtotal pancreatic necrosis on computed tomography (OR 9.49; 95% CI 6.31-14.29) and a high level of serum C-reactive protein in the first 48 hours after admission (per 10-point increase, OR 1.02; 95% CI 1.00-1.03) were identified as independent predictors for developing DPD.

DISCUSSION:

At least 1 of every 4 patients with necrotizing pancreatitis experience DPD, which is associated with detrimental, short-term and long-term interventions, and complications. Central and subtotal pancreatic necrosis and high levels of serum C-reactive protein in the first 48 hours are independent predictors for DPD.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite Necrosante Aguda Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite Necrosante Aguda Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda